VivaBioCell was founded in 2007 as a spin-off of University of Udine, Italy, following the experience gained by the European Space Agency project AO-99-003 Modular space bioreactor for medically relevant organ-like structures.
In 2015, it was fully acquired by NantCell Inc, a subsidiary of NantWorks LLC group, which supports an ecosystem of companies focused on the discovery and development of disease treatments through innovative therapies, operating at the intersection of innovation and infrastructure.
Today, VivaBioCell develops, manufactures and commercializes automated bioreactors to support advanced therapy medicinal product manufacturing for innovative and regenerative medicine therapies.
Mission & Vision
Our Mission is to encourage the diffusion of cell therapies through the development of products that allow the automation of manufacturing procedures, the increase of productivity and production capacity (scalability), risk reduction, cost containment and improvement of standardization, while maintaining compliance with regulatory and quality requirements.
The long-term vision of VivaBioCell is to make it possible for innovative therapies to become affordable to a large number of patients.
Quality & Compliance
Our Quality Management System includes standard operating procedures and work instructions covering Management of Quality Documentation, Management Responsibility, Design and Development, Product Realization, Commercialization, Process Measurement, Analysis and Improvement.